Back to Results
First PageMeta Content
Pharmacology / Business software / Sproxil / Business / Pharmaceuticals policy / Pharmaceutical industry / Counterfeit medications / National Agency for Food and Drug Administration and Control / Counterfeit / Counterfeit consumer goods / Health / Pharmaceutical sciences


Acumen Fund Invests in Sproxil, Inc. to Combat Counterfeit Medicine Using Mobile Technology Investment Will Help Sproxil Build Sales Teams, Expand into India and Kenya, and Make Improvements to the Technology New York, N
Add to Reading List

Document Date: 2014-03-07 17:13:00

Open Document

File Size: 143,96 KB

Share Result on Facebook

City

New York / /

Company

Johnson & Johnson / Sproxil Inc. / GSK / PRWEB / NAFDAC / Acumen Fund / /

Continent

Africa / /

Country

Kenya / Pakistan / United States / Nigeria / Ghana / India / /

Currency

USD / /

Event

M&A / Funding / Business Partnership / /

Facility

Dartmouth College / /

IndustryTerm

Online Web / healthcare crisis / pharmaceutical product / cellular networks / mobile technology / online version / sales teams / Counterfeit products / informed pharmaceutical purchasing decisions / pharmaceutical / online visibility tool / counterfeit product / energy / pharmaceutical counterfeiters / /

Organization

Nigerian Agency for Food / Drug and Administrative Control / United States Agency for International Development / World Health Organization / Nigerian Agency for Food / World Customs Organization / Acumen Fund Acumen Fund / Dartmouth College / /

Person

Ashifi Gogo / Jacqueline Novogratz / /

/

Position

CEO / co-Founder and CEO / /

Product

AuthenticationTM / /

Region

East Africa / South Asia / /

Technology

cellular telephone / SMS / mobile phones / /

URL

www.sproxil.com / www.acumenfundblog.org / www.acumenfund.org / /

SocialTag